Glenmark Pharmaceuticals has reported results for the quarter ended June 30, 2011.
The company‘s net profit has registered growth of 19.20% at Rs 72.46 crore for the quarter as compared to Rs 60.79 crore for the corresponding quarter of the previous year. Its total income has increased by 19.14% at Rs 330.78 crore for the Q1FY12 from Rs 277.62 crore for the Q1FY11.
On consolidated basis, the group’s net profit for the quarter ended June 30, 2011 has clocked in 23.20% growth at Rs 210.11 crore as compared to Rs 170.54 crore for the June quarter of the previous fiscal. Its total income has increased by 26.77% to Rs 880.80 crore for the quarter from Rs 694.81 crore for the June quarter of FY11.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1532.85 |
Dr. Reddys Lab | 5812.50 |
Cipla | 1403.90 |
Zydus Lifesciences | 1104.45 |
Lupin | 1661.90 |
View more.. |